2002
DOI: 10.3892/ijo.21.6.1285
|View full text |Cite
|
Sign up to set email alerts
|

Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (Review)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
93
1
4

Year Published

2004
2004
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 96 publications
(98 citation statements)
references
References 0 publications
0
93
1
4
Order By: Relevance
“…A variety of evidence indicates that leptin is highly correlated with obesity-related carcinoma, such as breast cancer (Rose et al 2002) and hepatocellular carcinoma (Saxena et al 2007). High leptin levels are associated with advanced tumor stage and higher tumor grade in breast cancer (Goodwin et al 2005).…”
Section: Discussionmentioning
confidence: 99%
“…A variety of evidence indicates that leptin is highly correlated with obesity-related carcinoma, such as breast cancer (Rose et al 2002) and hepatocellular carcinoma (Saxena et al 2007). High leptin levels are associated with advanced tumor stage and higher tumor grade in breast cancer (Goodwin et al 2005).…”
Section: Discussionmentioning
confidence: 99%
“…Recent reviews state that leptin is involved in increased susceptibility for cancer, particularly of the breast and prostate. [7][8][9][10] In this article we review the leptin pathway from the obesity state to PCa susceptibility and progression to advanced disease.…”
Section: Introductionmentioning
confidence: 99%
“…Numerous studies have established that obesity is a risk factor for breast cancer development in postmenopausal women (Cleary and Maihle, 1997;Chlebowski et al, 2002;Rose et al, 2002;Stephenson and Rose, 2003). Notably, a large body of evidence suggests that postmenopausal obesity, assessed by BMI, is associated with the increased risk of developing hormonedependent breast cancer (i.e., ER and progesterone receptor (PR)-positive tumors), but not with the incidence of ER/PR-negative tumors (Potter et al, 1995;Enger et al, 2000;.…”
Section: Breast Cancermentioning
confidence: 99%